This is the 20th year for the International Symposium on Ventricular Arrhythmias: Pathophysiology and Therapy. Using a combination of didactic presentations, panel discussions, and question and answer sessions, our goal is to educate the participants in state of the art information regarding the pathophysiology and treatment of ventricular arrhythmias. The structure of the symposium sessions is meant to be highly interactive. There will also be VT ablation cases streamed live from the Hospital of the University of Pennsylvania and pre-recorded cases from Mount Sinai Hospital, Beth Israel, and Cleveland Clinic during which a moderated panel discussion and question and answer session will occur to educate and demonstrate to the audience members the most up to date mapping and ablation techniques for complex ventricular arrhythmias.
The program is taught by a select group of international leaders and pioneers in the field of electrophysiology, pathology, pharmacology, radiology and basic/translational research including members of the faculty from the University of Pennsylvania Health System, Department of Electrophysiology. The course is structured to meet the educational needs of electrophysiologists, cardiologists, and allied professionals with an interest in the care of patients with ventricular arrhythmias. The faculty have all been strongly urged to present cutting edge information with the aim of forwarding the field through discussion and sharing of information. Cutting edge research will be presented at a Late Breaking Trials session, and there is an abstract competition for fellows/early career researchers with the finalists presenting their information at the symposium.
Learning Objectives
- Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease including new ablation techniques and technologies
- Discuss the status and future role for device therapy in the management of sudden cardiac death and heart failure
- Discuss the role of new techniques for VT substrate assessment including high density mapping, MRI and other imaging techniques, and use of artificial intelligence
- Describe risk stratification for sudden death and treatment, including VF ablation, in patients with VF due to various substrates and syndromes
- Identify the challenges related to treatment of PVCs and idiopathic VT
- Describe the status of ongoing multicenter VT related trials and discuss future directions and questions to be answered
- Describe the science critical to the understanding and treatment of ventricular arrhythmias, including:
- The role of the autonomic nervous system in ventricular arrhythmogenesis
- The anatomic substrate for ventricular arrhythmias
Location
Philadelphia Marriott Downtown
1201 Market Street
Philadelphia, PA
United States
Program Directors
Francis Marchlinski, MD, FHRS
David Callans, MD
Andre d'Avila, MD, PhD
Vivek Reddy, MD
Srinivas Dukkipati, MD
Location
- Philadelphia Marriott Downtown
-
- Philadelphia
- PA
- United States
- See map here
Topic
- Ablation
- Device Therapy
- Sudden Cardiac Arrest
- Ventricular Arrythmias
Delivery Method
In-Person, Virtual
Event Type
Synchrony